Name | Vicasinabin |
---|
Description | Vicasinabin is the potent agonist of cannabinoid receptor 2 (CB2). Vicasinabin has the potential for the research of human diseases including chronic pain, atherosclerosis, regulation of bone mass, neuroinflammation, and other related diseases (extracted from patent US20130116236A1)[1]. |
---|---|
Related Catalog | |
Target |
CB2[1] |
References |
[1]. Jean-Michel Adam, et al. Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives. Patent US20130116236A1. |
Molecular Formula | C15H22N10O |
---|---|
Molecular Weight | 358.40 |